EVGN Evogene Ltd. - Ordinary Shares

NASDAQ · Biotechnology
$0.57
Price · Aug 19, 2026

EVGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.57
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$0 – $2

EVGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
EVGN
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
EVGN
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
EVGN
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
EVGN
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
EVGN
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
EVGN
Peer Median

EVGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

1 analysts · 2026-08-16
Median target $2.15 +274.4%
Mean target $2.15 +274.4%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.06%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.13 $-0.28
March 31, 2026 $-0.60 $-0.28 -0.32%
Dec. 31, 2025 $-0.61 $-0.27 -0.34%
Sept. 30, 2025 $0.44 $-0.42 0.86%
June 30, 2025 $-0.62 $-0.64 0.02%
March 31, 2025 $-0.38 $-0.46 0.08%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
EVGN
PLUR $39M -1.4 309.8% -1690.3% 669.5% 48.9%
NRSN
CMMB
QNRX $757M -201.7%
CLGN
GLMD
SCNI
URGN $1.13B 21.4% -139.8% 154.4% 88.7%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 13 filers · $70K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
3 (0 vs prior Q) 5 (0 vs prior Q) 1 (0 vs prior Q) 4 (-1 vs prior Q) -253K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
SUSQUEHANNA INTERNATIONAL GROUP, LLP $33,889 80,078 48.18% Shares
CITADEL ADVISORS LLC $21,383 50,526 30.40% Shares
XTX Topco Ltd $8,212 19,404 11.67% Shares
Daytona Street Capital LLC $4,651 9,253 6.61% Shares
BNP PARIBAS FINANCIAL MARKETS $1,242 2,830 1.77% Shares
MORGAN STANLEY $555 1,264 0.79% Shares
Federation des caisses Desjardins du Quebec $220 500 0.31% Shares
UBS Group AG $46 104 0.07% Shares
HRT FINANCIAL LP $45 107,198 0.06% Shares
OSAIC HOLDINGS, INC. $44 100 0.06% Shares
SHP Wealth Management $29 65 0.04% Shares
SBI Securities Co., Ltd. $27 62 0.04% Shares
ROYAL BANK OF CANADA $0 42 0.00% Shares

Company insiders 1 insider · 0 officers · 0 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
RECANATI LEON Aug. 11, 2026 P 1,343,886 2 0 $694,400

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 2 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
L.I.A. Pure Capital Ltd., Kfir Silberman, Invest Pro Shukai Hon Ltd., Ron Yair Peled ×5 filings Aug. 13, 2026 19.35% Amendment SEC
RECANATI LEON ×2 filings Aug. 13, 2026 8.60% Amendment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.